Skip to main content
. Author manuscript; available in PMC: 2017 Oct 20.
Published in final edited form as: Thromb Res. 2008 Nov 21;124(3):323–327. doi: 10.1016/j.thromres.2008.09.007

Figure 5. The CUB-1 mutations did not impair VWF binding.

Figure 5

The binding of the CUB-1 mutants at various concentrations (0.5, 1.0, 2.0 μg/ml) to the purified VWF multimers was measured under static conditions. Consistent with the activity measurements, all three mutants bound immobilized VWF at levels similar to each other and to WT (ANOVA test, n = 4, p > 0.05 among WT and mutants).